Brussels strengthens ties with Canada and rolls out new anti-drug rules
The 21st EU-Canada summit launches a Future Partnership Alliance towards a closer association without full membership. Meanwhile, the EU Council approves new rules on chemical drug precursors.
The 21st summit between the European Union and Canada has produced a step that both sides describe as significant in their long-standing partnership: the launch of a Future Partnership Alliance, designed to deepen bilateral cooperation.
According to a statement from the Council of the European Union, leaders from both sides will now work to define an increasingly closer association of Canada with the Union, without this entailing full membership of the EU bloc. This is an intermediate formula, one that distinguishes the new phase of cooperation from an actual enlargement path, reserved for countries that are candidates for joining the Union.
The news currently stems from a single source, the Council of the European Union; no independent confirmation is available in the material gathered regarding the contents of the agreement or the next steps of the announced path.
Within the same institutional framework, the EU Council has in recent days rolled out a second measure, distinct from the summit with Ottawa but attributable to the same decision-making body: new measures to combat the illegal production of drugs. The core of the measure concerns chemical precursors, that is, substances which, despite having legitimate uses in other sectors, can be diverted towards the manufacture of illicit drugs. The Council approved updated rules on these products as part of the broader fight against drug trafficking at the European level.
In this case too, the material gathered traces the news back to a single institutional source, the Council of the European Union, with no independent confirmation available on the implementation details of the new rules.
The two dossiers, although distinct in content, share the same working week of the European institutions: on one hand, the opening of a strengthened cooperation channel with a long-standing non-European partner; on the other, an internal regulatory intervention designed to make it more difficult to source chemical substances used in the production of illegal drugs. Both measures remain, as things currently stand in the available documentation, official statements from European institutions without independent press confirmation.
← Archive · Front page · Past editorials · Report an error · Original article (in Italian)